SCHEMBL14924653

SCHEMBL14924653

c1ccc(-n2c3cccc4c5ccccc5c5c(c43)-c3c4c(cccc4n5-c4ccccc4)c4ccccc4c32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ MAPK1 P28482 2/20 0.42
▸ KMT2A Q03164 2/20 0.38
▸ PGR P06401 3/20 0.38
▸ MAPK8 P45983 2/20 0.35
▸ IL1R1 P14778 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALKBH5 Q6P6C2 1/20 0.34
▸ FTO Q9C0B1 1/20 0.34
▸ HTT P42858 2/20 0.34
▸ MAPK9 P45984 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HKDC1 Q2TB90 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14924645 0.85 KDM4E (0.40) L3MBTL1KDM4EATMMAPK1ALDH1A1
SCHEMBL14924652 0.82 HSD17B10 (0.35) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL12698517 0.82 L3MBTL1 (0.67) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL14924649 0.81 KDM4E (0.34) L3MBTL1KDM4EATMKMT2AALDH1A1
SCHEMBL12249843 0.81 L3MBTL1 (0.59) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL22019253 0.80 KDM4E (0.44) L3MBTL1KDM4EATMMAPK1PGR
SCHEMBL18435750 0.79 L3MBTL1 (0.63) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL19890936 0.79 L3MBTL1 (0.57) L3MBTL1KDM4EATMMAPK1KMT2A
SCHEMBL10028225 0.79 TDP1 (0.44) KDM4EMAPK1KMT2AALDH1A1HSD17B10
SCHEMBL14924648 0.78 L3MBTL1 (0.39) L3MBTL1KDM4EATMMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079903-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-07-14 — — US disclosed
US-9079903-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-07-14 — — US disclosed
US-20130112946-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-05-09 — — US disclosed
US-20130112946-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130112946-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, NR2E3, CRY2 L3MBTL1 307/4885KDM4E 2371/4885ATM 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback